T Cell Inflamed Gene Expression Profiling Score-guided Anti PD-1 Therapy (Tislelizumab Monotherapy) for Refractory Solid Cancer Patients Unexposed to Immunotherapy

NCT07300891 · clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
72
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Samsung Medical Center